← Return to Monitoring for reoccurrence

Discussion

Monitoring for reoccurrence

Esophageal Cancer | Last Active: Dec 16 9:12am | Replies (5)
Comment receiving replies
@jdcourier

Thank you for explaining all this. Do you know why it’s difficult to spot in early stages, and if there are any definitive testing available to spot early onset, before it reaches a stage 2 and 3 level?

Jump to this post

Replies to "Thank you for explaining all this. Do you know why it’s difficult to spot in early..."
davidwrenn | @davidwrenn | Dec 16 9:12am

It's a matter of cell numbers detected in the analysis of the biopsy. Often in early phases of the disease signet cells are not a majority of the dysplastic cells that may appear in the biopsies. It's also dependent upon obtaining biopsy samples from areas of the tumor or nodes that may be enriched for signet cells.

VIEW AND REPLY